Alchemab Therapeutics has appointed Ulrich Wendt, PhD MBA, as Chief Business Officer to expand partnerships with biopharma for the development of novel antibody therapeutics. Dr. Wendt will lead the company's business development and alliance management efforts.
Company Information
Company
Alchemab Therapeutics
Location
London, England, United Kingdom
About
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.
Alchemab takes an unbiased and function-first approach using three complementary processes and cutting-edge technologies to identify naturally protective antibodies.
Alchemab’s engine is enabled through collaborations with patient representative groups and biobanks around the world with whom we partner to further our understanding of disease.
LondonBiotechnologyHealth CareTherapeuticsPharmaceutical